Brainstorm Cell Therapeutics reported $7.49M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Biogen USD 430.3M 26.4M Sep/2026
Brainstorm Cell Therapeutics USD 7.49M 171K Jun/2026
Cipla INR 32.66B 361.1M Sep/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.15M 371K Jun/2026
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 25.96M 5.45M Sep/2026
Gilead Sciences USD 934M 260M Sep/2026
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 33.55M 9.94M Sep/2026
Mesoblast USD 46.81M 13.23M Jun/2026